Reports Second Consecutive Year of over
Significant Profitability Expansion with 51% Gross Margin for FY 2026
FY 2026 Operating Income Increased 81% and Net Income Increased 42% Year-Over-Year
Backlog Remains Strong at
Anticipating Continued Revenue Growth in 1H 2027 Driven by Strong Medical Sector and High-ASP Systems
Conference call scheduled for
“We are greatly encouraged by our fiscal 2026 results, highlighted by strong profitability expansion and uninterrupted revenue consistency. We achieved our second consecutive year of revenue over
“Margin expansion in the year was driven primarily by favorable product mix, including a higher concentration of high-ASP production systems, as well as a greater percentage of sales in the U.S. market, where we benefit from stronger margins by bypassing international-business costs.”
“We are seeing strong momentum in the medical sector, with growing demand across applications such as stent coating, balloon catheter systems, and diagnostic devices. In addition, our electronics business continues to expand, particularly in electrically active coatings for diagnostic-related applications that leverage our core coating technologies. While clean energy remains an important long-term opportunity, near-term orders for electrolysis-related systems have declined, mirroring softening demand that has resulted from government policy changes and elimination of incentives. This was partially offset by solar system shipments earlier in the fiscal year.”
“Looking ahead, we anticipate continued revenue growth in the first half of FY 2027 and profitability driven by the medical sector and sustained demand for high-ASP production systems. For FY 2027, we anticipate relatively flat to modestly higher year over year revenue, with continued uncertainty in certain clean energy sectors and the timing of high ASP customer orders, that are more complex and typically involve longer lead times.
We believe our strategy is succeeding, and we remain confident in our ability to deliver long-term revenue growth and profitability.”
Dr.
“We are pleased with the Company’s continued execution and improving financial performance. We are proud to report that FY 2026 marks our third consecutive year of annual revenue growth and sixteenth year in a row of profitability. Our strong backlog, supported by demand for complex, production-oriented systems, provides a solid foundation as we move forward. Sono-Tek’s ability to adapt to changing market conditions, while maintaining focus on high-value opportunities, continues to differentiate the Company. We remain confident in our long-term strategy and growth trajectory.”
Fiscal Year 2026 Highlights
Net Sales : $20.9 million, up 2% from$20.5 million in FY 2025, reflecting continued demand for high-ASP production systems and growth in medical and electronics markets.- Gross Profit: $10.56 million, up 8% from
$9.74 million in the prior year. Gross margin increased to 51% from 47.5%, driven by favorable product mix and increasedU.S. -based system sales. - Operating Income: $1.82 million, up 81% from
$1.01 million in FY 2025, reflecting improved operating leverage and higher-margin system shipments. - Net Income: Approximately
$1.8 million , up 42% from$1.27 million in FY 2025, reflecting strong margin expansion and improved profitability.
| Fiscal 2026 Review | (Results compared with fiscal 2025) | ||||||||
| ($ in thousands) | |||||||||
| Change | |||||||||
| FY 2026 | FY 2025 | $ | % | ||||||
| $ | 20,909 | $ | 20,504 | 405 | 2 | % | |||
| Gross Profit | $ | 10,560 | $ | 9,739 | 821 | 8 | % | ||
| Gross Profit | 51% | 48% | 3 | % | |||||
| Operating Income | $ | 1,825 | $ | 1,010 | 815 | 81 | % | ||
| Operating Margin | 9% | 5% | 4 | % | |||||
| Net Income | $ | 1,806 | $ | 1,273 | 533 | 42 | % | ||
| 9% | 6% | 2 | % | ||||||
Fourth Quarter Fiscal 2026 Highlights
Net Sales : $5.6 million, up 10% from$5.12 million in Q4 FY 2025.- Gross Profit: $2.79 million, up 15% from
$2.43 million in the prior-year period, with gross margin increasing to 50%. - Net Income: $557,043, up 70% from
$327,714 in Q4 FY 2025.
| Fourth Quarter Fiscal 2026 Review | (Results compared with the fourth quarter offiscal 2025) | ||||||||
| ($ in thousands) | |||||||||
| Change | |||||||||
| FY 2026 | FY 2025 | $ | % | ||||||
| $ | 5,609 | $ | 5,121 | 488 | 10 | % | |||
| Gross Profit | $ | 2,793 | $ | 2,425 | 368 | 15 | % | ||
| Gross Profit | 50% | 47% | 3 | % | |||||
| Operating Income (Loss) | $ | 601 | $ | 288 | 313 | 109 | % | ||
| Operating Margin | 11% | 6% | 5 | % | |||||
| Net Income | $ | 557 | $ | 328 | 229 | 70 | % | ||
| 10% | 6% | 4 | % | ||||||
Balance Sheet, Backlog and Outlook
Balance Sheet: The Company ended the fiscal year with
Backlog: Equipment and service-related backlog remained strong at approximately
Outlook: Sono-Tek anticipates continued revenue growth and profitability in the first half of fiscal year 2027 compared to the first half of FY 2026, driven by expanding demand in the medical sector and continued adoption of high-ASP, production-scale coating systems across multiple end markets. Total FY 2027 revenue is currently projected to be relatively flat to modestly higher compared to FY 2026 as visibility beyond the first half remains limited due to continued uncertainty in certain clean energy sectors and the timing of high ASP customer orders, which can create significant shifts in quarterly delivery timing.
Fiscal Year 2026 Product and Market Highlights
End Markets:
- Medical: Increased 54%, driven by strong demand for balloon catheter coating systems, specialty stent applications, and expanding activity in new medical applications.
- Electronics: Increased 16%, supported by strong demand for electrically active coatings in diagnostic-related applications.
- Alternative/Clean Energy: Declined 19% due to reduced electrolysis demand driven by government policy shifts, partially offset by solar system shipments earlier in the fiscal year.
Product Categories:
- In-Line Coating Systems (formerly referred to as Integrated Coating Systems): Increased 91%, driven by shipments of eight high-ASP systems to a solar customer.
- Fluxing Systems: Increased 53%, supported by strong sales in Asia.
- Multi-Axis Systems: Declined due to reduced demand in electrolysis-related applications.
To participate, please call 1-844-481-2752 or 1-412-317-0668 for international callers at least 10 minutes prior to the start of the call and ask to join the
A simultaneous webcast of the call may be accessed through the Company's website, Events & Presentations |
https://event.choruscall.com/mediaframe/webcast.html?webcastid=6cEJqpHo
A replay of the call will be available at 1-855-669-9658 or 1-412-317-0088 for international callers, access code 7754993, through
About
Our product line is rapidly evolving, transitioning from R&D to high-volume production machines with significantly higher average selling prices, showcasing our market leadership and adaptability. Our comprehensive suite of thin film coating solutions and application consulting services are expected to generate unparalleled results for our clients and help some of the world's most promising companies achieve technological breakthroughs and bring them to the market. We strategically deliver our products to customers through a network of direct sales personnel, carefully chosen independent distributors, and experienced sales representatives, ensuring efficient market reach across diverse sectors around the globe.
Our solutions are environmentally friendly, efficient and highly reliable, and enable dramatic reductions in overspray, savings in raw material, water and energy usage and provide improved process repeatability, transfer efficiency, high uniformity and reduced emissions.
Our growth strategy is focused on leveraging our innovative technologies, proprietary know-how, unique talent and experience, and global reach to further develop thin film coating technologies that enable better outcomes for our customers’ products and processes. For further information, visit www.sono-tek.com
Safe Harbor Statement
This news release contains forward looking statements regarding future events and the future performance of
For more information:
Chief Financial Officer
Ph: (845) 795-2020
info@sono-tek.com
Investor Relations
ksmith@pcgadvisory.com
- Financial Tables to follow –
CONSOLIDATED BALANCE SHEETS | ||||||||||
2026 | 2025 | |||||||||
| ASSETS | ||||||||||
| Current Assets: | ||||||||||
| Cash and cash equivalents | $ | 7,339,403 | $ | 5,202,361 | ||||||
| Marketable securities | 7,469,649 | 6,727,678 | ||||||||
| Accounts receivable (less allowance for credit losses of | 3,350,953 | 2,347,764 | ||||||||
| Inventories | 3,923,350 | 4,474,401 | ||||||||
| Prepaid expenses and other current assets | 743,295 | 236,261 | ||||||||
| Total current assets | 22,826,650 | 18,988,465 | ||||||||
| Land | 250,000 | 250,000 | ||||||||
| Buildings, equipment, furnishings and leasehold improvements, net | 2,173,443 | 2,610,600 | ||||||||
| Intangible assets, net | 29,791 | 37,386 | ||||||||
| Deferred tax asset | 1,141,611 | 1,525,185 | ||||||||
| TOTAL ASSETS | $ | 26,421,495 | $ | 23,411,636 | ||||||
| LIABILITIES AND STOCKHOLDERS’ EQUITY | ||||||||||
| Current Liabilities: | ||||||||||
| Accounts payable | $ | 1,038,885 | $ | 859,483 | ||||||
| Accrued expenses | 2,227,401 | 1,718,574 | ||||||||
| Customer deposits | 3,069,743 | 2,413,195 | ||||||||
| Income taxes payable | 255,398 | 496,055 | ||||||||
| Total current liabilities | 6,591,427 | 5,487,307 | ||||||||
| Deferred tax liability | 55,909 | 132,134 | ||||||||
| Total Liabilities | 6,647,336 | 5,619,441 | ||||||||
| Commitments and Contingencies (Note 13) | ||||||||||
| Stockholders’ Equity | ||||||||||
| Common stock, | 157,104 | 157,512 | ||||||||
| Additional paid-in capital | 10,186,858 | 10,018,034 | ||||||||
| Accumulated earnings | 9,430,197 | 7,624,516 | ||||||||
| - | (7,867 | ) | ||||||||
| Total stockholders’ equity | 19,774,159 | 17,792,195 | ||||||||
| TOTAL LIABILITIES AND STOCKHOLDERS’ EQUITY | $ | 26,421,495 | $ | 23,411,636 | ||||||
CONSOLIDATED STATEMENTS OF INCOME | |||||||||
2026 | 2025 | ||||||||
| $ | 20,909,315 | $ | 20,504,381 | ||||||
| Cost of Goods Sold | 10,349,373 | 10,765,362 | |||||||
| Gross Profit | 10,559,942 | 9,739,019 | |||||||
| Operating Expenses | |||||||||
| Research and product development | 2,553,898 | 2,724,482 | |||||||
| Marketing and selling | 3,525,239 | 3,677,915 | |||||||
| General and administrative | 2,655,836 | 2,326,582 | |||||||
| Total Operating Expenses | 8,734,973 | 8,728,979 | |||||||
| Operating Income | 1,824,969 | 1,010,040 | |||||||
| Other Income: | |||||||||
| Interest and dividend income | 443,588 | 488,504 | |||||||
| Net unrealized gain on marketable securities | (1,498 | ) | 35,548 | ||||||
| Income before Income Taxes | 2,267,059 | 1,534,092 | |||||||
| Income Tax Expense | 461,378 | 260,678 | |||||||
| Net Income | $ | 1,805,681 | $ | 1,273,414 | |||||
| Basic Earnings Per Share | $ | 0.11 | $ | 0.08 | |||||
| Diluted Earnings Per Share | $ | 0.11 | $ | 0.08 | |||||
| Weighted Average Shares – Basic | 15,718,796 | 15,750,997 | |||||||
| Weighted Average Shares – Diluted | 15,733,825 | 15,770,102 | |||||||
PRODUCT, MARKET, AND GEOGRAPHIC SALES (Unaudited) | ||||||||||||||||||||||||
| Product Sales: | ||||||||||||||||||||||||
| Twelve Months Ended | ||||||||||||||||||||||||
| % of | % of | Change | ||||||||||||||||||||||
| 2026 | Total | 2025 | total | $ | % | |||||||||||||||||||
| Fluxing Systems | $ | 713,000 | 3 | % | $ | 467,000 | 2 | % | $ | 246,000 | 53 | % | ||||||||||||
| In-Line Coating Systems | 7,070,000 | 34 | % | 3,703,000 | 18 | % | 3,367,000 | 91 | % | |||||||||||||||
| Multi-Axis Coating Systems | 8,055,000 | 39 | % | 10,678,000 | 52 | % | (2,623,000 | ) | (25 | %) | ||||||||||||||
| OEM Systems | 1,210,000 | 6 | % | 1,484,000 | 7 | % | (274,000 | ) | (18 | %) | ||||||||||||||
| Other | 3,861,000 | 18 | % | 4,172,000 | 21 | % | (311,000 | ) | (7 | %) | ||||||||||||||
| TOTAL | $ | 20,909,000 | $ | 20,504,000 | $ | 405,000 | 2 | % | ||||||||||||||||
| Market Sales: | ||||||||||||||||||||||||
| Twelve Months Ended | ||||||||||||||||||||||||
| % of | % of | Change | ||||||||||||||||||||||
| 2026 | Total | 2025 | total | $ | % | |||||||||||||||||||
| Electronics/Microelectronics | $ | 6,290,000 | 30 | % | $ | 5,426,000 | 27 | % | $ | 864,000 | 16 | % | ||||||||||||
| Medical | 5,004,000 | 24 | % | 3,250,000 | 16 | % | 1,754,000 | 54 | % | |||||||||||||||
| Alternative Energy | 7,974,000 | 38 | % | 9,838,000 | 48 | % | (1,864,000 | ) | (19 | %) | ||||||||||||||
| Emerging R&D and Other | 66,000 | 0 | % | 67,000 | 0 | % | (1,000 | ) | (1 | %) | ||||||||||||||
| Industrial | 1,575,000 | 8 | % | 1,923,000 | 9 | % | (348,000 | ) | (18 | %) | ||||||||||||||
| TOTAL | $ | 20,909,000 | $ | 20,504,000 | $ | 405,000 | 2 | % | ||||||||||||||||
| Geographic Sales: | ||||||||||||||||
| Twelve Months Ended | ||||||||||||||||
| Change | ||||||||||||||||
| 2026 | 2026 | $ | % | |||||||||||||
| $ | 13,946,000 | $ | 12,506,000 | $ | 1,440,000 | 12 | % | |||||||||
| 2,630,000 | 2,758,000 | (128,000 | ) | (5 | %) | |||||||||||
| 3,742,000 | 4,431,000 | (689,000 | ) | (16 | %) | |||||||||||
| 591,000 | 809,000 | (218,000 | ) | (27 | %) | |||||||||||
| TOTAL | $ | 20,909,000 | $ | 20,504,000 | $ | 405,000 | 2 | % | ||||||||
Source: